InVivo Therapeutics Holdings Corp. (NVIV) Analysts See $-0.13 EPS; Johnson Investment Counsel Increased Cigna (CI) Position

April 28, 2018 - By Marie Mckinney

Cigna Corporation (NYSE:CI) Logo

Johnson Investment Counsel Inc increased Cigna Corporation (CI) stake by 57.76% reported in 2017Q4 SEC filing. Johnson Investment Counsel Inc acquired 1,548 shares as Cigna Corporation (CI)’s stock declined 18.61%. The Johnson Investment Counsel Inc holds 4,228 shares with $858,000 value, up from 2,680 last quarter. Cigna Corporation now has $42.31B valuation. The stock increased 1.05% or $1.8 during the last trading session, reaching $173.95. About 1.49 million shares traded. Cigna Corporation (NYSE:CI) has risen 13.35% since April 28, 2017 and is uptrending. It has outperformed by 1.80% the S&P500.

Analysts expect InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) to report $-0.13 EPS on May, 3.They anticipate $0.07 EPS change or 35.00% from last quarter’s $-0.2 EPS. After having $-0.13 EPS previously, InVivo Therapeutics Holdings Corp.’s analysts see 0.00% EPS growth. The stock increased 21.17% or $1.37 during the last trading session, reaching $7.84. About 85,263 shares traded or 193.98% up from the average. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) has declined 87.02% since April 28, 2017 and is downtrending. It has underperformed by 98.57% the S&P500.

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focus on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company has market cap of $12.25 million. It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for acute SCI; and Therapeutic Trails injection program for the treatment of chronic SCI. It currently has negative earnings.

Investors sentiment decreased to 0.91 in 2017 Q4. Its down 0.05, from 0.96 in 2017Q3. It turned negative, as 38 investors sold CI shares while 280 reduced holdings. 92 funds opened positions while 197 raised stakes. 208.24 million shares or 0.93% more from 206.32 million shares in 2017Q3 were reported. The New York-based Silvercrest Asset Management Lc has invested 0.01% in Cigna Corporation (NYSE:CI). Boston Private Wealth Lc reported 6,477 shares. Private Na has invested 0.09% in Cigna Corporation (NYSE:CI). Shikiar Asset Inc holds 0.86% or 9,050 shares. Bp Public Ltd Company holds 29,000 shares. 1,000 are held by Oarsman Capital. Moreover, Wolverine Asset Mgmt Ltd Co has 0% invested in Cigna Corporation (NYSE:CI) for 129 shares. Alliancebernstein Lp, New York-based fund reported 2.49 million shares. Cramer Rosenthal Mcglynn Lc invested in 0% or 1,000 shares. Systematic Mngmt Limited Partnership owns 9,478 shares for 0.04% of their portfolio. Jennison Assoc Limited Company owns 1.15M shares. Advsr Asset holds 0.01% in Cigna Corporation (NYSE:CI) or 2,502 shares. Jpmorgan Chase Com holds 5.32M shares or 0.23% of its portfolio. The New York-based Evercore Wealth Mgmt Llc has invested 0% in Cigna Corporation (NYSE:CI). Tradewinds Mngmt Lc owns 180 shares for 0.02% of their portfolio.

Johnson Investment Counsel Inc decreased 3M Company (NYSE:MMM) stake by 8,063 shares to 124,897 valued at $29.40 million in 2017Q4. It also reduced General Electric Company (NYSE:GE) stake by 204,801 shares and now owns 536,197 shares. Emerson Electric Company (NYSE:EMR) was reduced too.

Since December 11, 2017, it had 0 insider purchases, and 10 selling transactions for $17.30 million activity. 5,971 shares were sold by ZARCONE DONNA F, worth $1.29 million on Tuesday, January 16. $7.05 million worth of Cigna Corporation (NYSE:CI) was sold by Cordani David. Jones Nicole S sold $1.12 million worth of Cigna Corporation (NYSE:CI) on Friday, March 2. Another trade for 6,099 shares valued at $1.34M was made by MURABITO JOHN M on Thursday, January 18. The insider Hocevar Christopher J sold 2,759 shares worth $529,287. $37,890 worth of Cigna Corporation (NYSE:CI) shares were sold by ZOLLARS WILLIAM D. 400 shares were sold by HENNEY JANE E MD, worth $85,184 on Friday, January 12.

Among 22 analysts covering CIGNA (NYSE:CI), 18 have Buy rating, 0 Sell and 4 Hold. Therefore 82% are positive. CIGNA had 65 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, March 26 by Jefferies. As per Wednesday, January 6, the company rating was maintained by Barclays Capital. The firm has “Hold” rating given on Wednesday, January 3 by Goldman Sachs. The stock of Cigna Corporation (NYSE:CI) has “Buy” rating given on Wednesday, August 5 by Zacks. The stock of Cigna Corporation (NYSE:CI) has “Overweight” rating given on Friday, February 2 by Morgan Stanley. The company was maintained on Friday, October 13 by Jefferies. The firm earned “Buy” rating on Tuesday, October 31 by Piper Jaffray. On Thursday, July 13 the stock rating was maintained by Deutsche Bank with “Buy”. The rating was maintained by RBC Capital Markets on Monday, November 9 with “Sector Perform”. The rating was maintained by UBS with “Buy” on Monday, June 5.

Cigna Corporation (NYSE:CI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: